Clinical trial
A Proof of Concept, Multicentre, Phase 2, Double-Blind, Randomized, Placebo-Controlled Study on the Efficacy, Safety and Tolerability of d-Methadone in Moderate to Very Severe Restless Legs Syndrome With Periodic Limb Movements: the Glu-REST Study
NCT04145674 is registered in ClinicalTrials.gov with Mauro Manconi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Proof of Concept, Multicentre, Phase 2, Double-Blind, Randomized, Placebo-Controlled Study on the Efficacy, Safety and Tolerability of d-Methadone in Moderate to Very Severe Restless Legs Syndrome With Periodic Limb Movements: the Glu-REST Study
- Lead sponsor
- Mauro Manconi
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- October 22, 2022
- Completion date
- December 30, 2026
- Enrollment
- 50 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.